# Boston Bioprocess, Inc. — Form D

Boston Bioprocess, Inc. of CHAMPAIGN, IL, a company, filed a Form D exempt-offering notice with the SEC on 2024-07-10. The offering totals $6.5M, of which $6.3M was reported sold. Industry: Other Technology.

## Offering

- Filed: 2024-07-10
- Form: D
- Accession: 0002029645-24-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $6.5M
- Amount sold: $6.3M
- Remaining: $260K
- Investors: 14
- Date of first sale: 2024-07-03
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-518230

## Issuer

- Name: Boston Bioprocess, Inc.
- CIK: 0002029645
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 60 HAZELWOOD DRIVE, CHAMPAIGN, IL, 61820
- Phone: 402-617-9036

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| JAMES CAFFYN | Director | CHICAGO, IL |
| Ted Netland | Director | Champaign, IL |
| Michael Tai | Director | Champaign, IL |
| Ted Netland | Executive Officer | Champaign, IL |
| Michael Tai | Executive Officer | Champaign, IL |

## More

- [CIK 2029645 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2029645&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002029645-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.